Correlation Between Central Reinsurance and Golden Biotechnology

Can any of the company-specific risk be diversified away by investing in both Central Reinsurance and Golden Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Central Reinsurance and Golden Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Central Reinsurance Corp and Golden Biotechnology, you can compare the effects of market volatilities on Central Reinsurance and Golden Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Central Reinsurance with a short position of Golden Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Central Reinsurance and Golden Biotechnology.

Diversification Opportunities for Central Reinsurance and Golden Biotechnology

0.08

Correlation Coefficient

Central Reinsurance  Golden Biotechnology

Significant diversification

The 3 months correlation between Central and Golden is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Central Reinsurance Corp and Golden Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Golden Biotechnology and Central Reinsurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Central Reinsurance Corp are associated (or correlated) with Golden Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Golden Biotechnology has no effect on the direction of Central Reinsurance i.e., Central Reinsurance and Golden Biotechnology go up and down completely randomly.

Pair Corralation between Central Reinsurance and Golden Biotechnology

Assuming the 90 days trading horizon Central Reinsurance is expected to generate 10.59 times less return on investment than Golden Biotechnology. But when comparing it to its historical volatility, Central Reinsurance Corp is 5.13 times less risky than Golden Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Golden Biotechnology is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,595  in Golden Biotechnology on September 29, 2024 and sell it today you would earn a total of  95.00  from holding Golden Biotechnology or generate 5.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Central Reinsurance Corp  vs.  Golden Biotechnology

Central Reinsurance Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Central Reinsurance Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Central Reinsurance is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Golden Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Golden Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Central Reinsurance and Golden Biotechnology

The main advantage of trading using opposite Central Reinsurance and Golden Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Central Reinsurance position performs unexpectedly, Golden Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Golden Biotechnology will offset losses from the drop in Golden Biotechnology's long position.

The idea behind Central Reinsurance Corp and Golden Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.